The Dallas–Fort Worth–Arlington metropolitan area features several top biotech and life sciences research institutions, which include the UNT Health Science Center, UT Southwestern, UT Dallas, UT Arlington, and the Baylor Research Center. Together, these five Dallas-area institutes advance biotech and life sciences discoveries and innovations for a wide range of treatments, cures, and other key health-related deliverables. It’s worth noting that UT Southwestern boasts 5 Nobel Laureates on its faculty, and invests $389 million annually in biomedical R&D, which aids in supporting the city’s strong commercialized biotech sector.
The city of Dallas also features the Southwestern Medical District (SMD), which is a 390-acre medical complex that is home to world-class biomedical research organizations that employ nearly 27,000. Member institutions include University Hospital-St.Paul, University Hospital-Zale Lipshy, the Children’s Medical Center Dallas, and Parkland Health & Hospital System. There are also some significant, planned SMD expansions, including new Parkland hospital facilities, a new $800 million state-of-the-art University Hospital, and a Children’s Medical Research Institute. Texas Oncology and the Mary Crowley Cancer Research Centers are also based in Dallas.
As a biotech hub, Dallas County is known to be particularly strong in ophthalmic goods manufacturing, while the north central region is regarded as a leader in medical equipment manufacturing. Furthermore, the number of ophthalmic goods manufacturing processionals concentrated in the Dallas/Fort Worth region contributes to the state of Texas having an ophthalmic goods sector workforce that is 20% higher than the national average.
The following are several key biotech and life science-related businesses with headquarters and/or a significant presence in Dallas:
Greatbatch, Inc.: which moved its headquarters to Frisco, Texas last year.
ZS Pharma, which makes frequent headlines about its ion-trap therapies that are being developed to treat serious medical conditions.
Caris Life Sciences is a leading provider of pathology technologies and offers customized molecular profiles of patient tumors to facilitate effective treatments .
Gradalis, a bio-pharmaceuticals company developing cancer therapeutics, has received $1.75 million in funding from the Texas Emerging Technology Fund, while Palmaz Scientific, a medical devices company developing the SESAME stent, has received $3 million.
The Dallas/Fort Worth region is also home to the U.S. headquarters of Dutch orthopedic firm OrthoFix International.